UNSPSC 51284114: Cefteram

This classification denotes a cephalosporin antibiotic with the molecular formula C16H17N9O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 74CQ4Q3N63, chemically known as (+)-(6r,7r)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-((5-methyl-2h-tetrazol-2-yl)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7(sup 2)-(z)-(o-methyloxime) but generally known as cefteram, which bears US NIH Compound Identifier 6537431.

UNSPSC 51284114 Cefteram is a Commodity code under which state and local governments procure pharmaceutical products, though the recent opportunities tagged to this code show little alignment with cefteram specifically. The Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse award through MMCAP Infuse to Chartwell Rx LLC supplied Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with two optional renewal years, totaling $2,999,999.11. A separate Seminole County, Florida procurement from June 2026 sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries. These opportunities reflect state health departments and county community health agencies as the primary issuing bodies, typically using cooperative purchasing vehicles and competitive bidding (IFB format) to source pharmaceutical and health-related products at scale.

Activity under this code appears geographically dispersed across state health agencies and county health authorities, with recent solicitations originating from Illinois and Florida. The Illinois Department of Public Health's contract, awarded under an Invitation for Bid process, demonstrates state-level pharmaceutical procurement through consortium agreements, while Seminole County's procurement shows county-level demand for emergency response and harm-reduction supplies. Neither recent opportunity explicitly named cefteram or beta-lactam antibiotics as scope items, suggesting that the code may see limited recent activity aligned with its nominal product category, or that state and local buyers are tagging pharmaceutical procurements across broader commodity groupings in practice.